Prospective comparison of whole-body MRI with diffusion-weighted and conventional imaging for the follow-up of neuroendocrine tumors.

Date publication

septembre 2019

Journal

Endocrine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr CADIOT Guillaume , Pr HOEFFEL Christine , Pr LEPAGE Côme

Tous les auteurs :
Minon M, Soriano C, Morland D, Walter T, Lepage C, Tabarin A, Deblock M, Rousset P, Barbe C, Hoeffel C, Cadiot G

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31564038

Résumé

To determine whether whole-body magnetic resonance imaging is valuable in staging of neuroendocrine tumors by comparison with the conventional imaging defined by the combination of computed tomography and somatostatin receptor scintigraphy.

Mots clés

Computed tomography, Diffusion-weighted, Magnetic resonance imaging, Neuroendocrine tumor, Positron-emission tomography, Somatostatin receptor scintigraphy

Référence

Endocrine. 2019 Sep 28;: